SMI-4a

SMI-4a is an inhibitor of PIM used in studies of JAK-STAT Signaling and Cell Cycle Regulation. In practice, this places the compound in experiments that measure cytokine-responsive transcriptional signaling and immune regulation and checkpoint control, mitotic progression, and proliferation timing in cancer and cell signaling models.

By inhibiting PIM, SMI-4a can be used to examine cytokine-responsive transcriptional signaling and immune regulation and checkpoint control, mitotic progression, and proliferation timing. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving PIM
• Pathway perturbation studies connected to JAK-STAT Signaling and Cell Cycle Regulation
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, SMI-4a is appropriate when a defined chemical perturbant is needed to connect PIM with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.